What is Chemed's stock-based comp?

Chemed (CHE) reported stock-based comp of $9.25M in Q1 2026.

How has Chemed's stock-based comp changed year-over-year?

Chemed's stock-based comp increased by 1.7% year-over-year, from $9.09M to $9.25M.

What is the long-term trend for Chemed's stock-based comp?

Over 4 years (2021 to 2025), Chemed's stock-based comp has grown at a 5.3% compound annual growth rate (CAGR), from $31.42M to $38.68M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Chemed CHE Stock-Based Comp

Stock-Based Comp at other companies

Option Care Health, Inc.OPCH

$10.2M+15.9%

ICU MedicalICUI

$14.01M+15.0%

GHC

Graham HoldingsGHC

$1.5M-3.2%

HCA HealthcareHCA

$86M-12.2%

Other financials

Income statement

See full

Revenue$657.5M+1.6%

Gross profit$215.8M-0.3%

Operating income$84.6M-10.7%

Net income$66.3M-7.6%

EPS (diluted)$4.84-0.4%

Balance sheet

See full

Cash & equivalents$16.9M-90.3%

Total debt$236.9M+63.3%

Total equity$848.0M-28.2%

Total assets$1.5B-11.0%

Cash flow

See full

Operating cash flow$88.2M+169%

CapEx$17.1M+28.9%

Free cash flow$71.1M+265%

Valuation

See full

Market cap$5.79B-42.3%

Profitability

See full

Gross margin32.4%-2.4pp

Operating margin12.9%-2.7pp

Net margin10.2%-2.2pp

FCF margin14.8%+2.2pp

Returns & leverage

See full

Return on equity25.6%-0.5pp

Debt / equity0.3×+0.2×

Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:StockOptionPlanExpense.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Chemed's stock-based comp?: Chemed (CHE) reported stock-based comp of $9.25M in Q1 2026.
How has Chemed's stock-based comp changed year-over-year?: Chemed's stock-based comp increased by 1.7% year-over-year, from $9.09M to $9.25M.
What is the long-term trend for Chemed's stock-based comp?: Over 4 years (2021 to 2025), Chemed's stock-based comp has grown at a 5.3% compound annual growth rate (CAGR), from $31.42M to $38.68M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.